Related Experiment Video
Updated: May 21, 2026
Conducting Respiratory Oscillometry in an Outpatient Setting
Published on: April 8, 2022
Identifying uncontrolled asthma in children with the childhood asthma control test or exhaled nitric oxide
Suleyman Tolga Yavuz1, Ersoy Civelek, Umit Murat Sahiner
1Faculty of Medicine, Pediatric Allergy and Asthma Unit, Hacettepe University, Ankara, Turkey.
Insights
The Childhood Asthma Control Test (C-ACT) is more effective than fractional exhaled nitric oxide (FeNO) in identifying poorly controlled asthma in children. C-ACT can serve as a valuable clinical tool for early detection of asthma control issues.
Area of Science:
- Pediatric Pulmonology
- Asthma Management
- Diagnostic Tools in Respiratory Medicine
Background:
- International guidelines emphasize assessing asthma control in children.
- There is an ongoing need for practical, objective tools to evaluate asthma control.
- Effective asthma management relies on accurate assessment of disease control status.
Purpose of the Study:
- To evaluate the effectiveness of the Childhood Asthma Control Test (C-ACT) and fractional concentration of exhaled nitric oxide (FeNO) in identifying children with not well-controlled asthma.
- To compare the diagnostic accuracy of C-ACT and FeNO in pediatric asthma patients.
- To determine the clinical utility of C-ACT and FeNO as biomarkers for asthma control.
Main Methods:
- A cohort of children aged 6-11 years with asthma participated in the study.
- Participants completed the C-ACT and underwent FeNO and spirometry measurements during monthly clinic visits.
- Asthma control was assessed by a specialist using the Global Initiative for Asthma guidelines.
Main Results:
- A C-ACT score of ≤22 demonstrated 69% sensitivity and 77% specificity for identifying not well-controlled asthma.
- FeNO levels of ≥19 ppb showed 61% sensitivity and 59% specificity after three visits.
- Receiver operating characteristic analysis indicated C-ACT (AUC=0.79) outperformed FeNO (AUC=0.58) in identifying poorly controlled asthma.
Conclusions:
- The C-ACT is a superior tool compared to FeNO for assessing asthma control in children.
- C-ACT can be utilized as a complementary diagnostic aid in clinical practice.
- Early identification of not well-controlled asthma in pediatric patients can be facilitated by C-ACT.
Background:
International guidelines highlight the importance of assessing asthma control status in children with asthma, and research on practical and objective instruments for assessing asthma control is ongoing.
Objective:
To determine the role of the Childhood Asthma Control Test (C-ACT) and fractional concentration of exhaled nitric oxide (FeNO) in identifying children with not well-controlled asthma.
Methods:
Children 6 to 11 years of age with asthma were enrolled in the study. They completed C-ACT and underwent FeNO and spirometric measurements during the monthly clinic visits. An asthma specialist assessed asthma control according to the gold standard Global Initiative for Asthma guideline and decided the treatment of the patients.
Results:
Seventy-six children with a mean (SD) age of 8.7 (1.4) years were evaluated in the first visit, whereas 64 and 51 children were admitted for second and third visits, respectively. A C-ACT score of 22 or less had 69% sensitivity and 77% specificity in determining not well-controlled asthma, whereas an FeNO value of 19 ppb or higher had 61% sensitivity and 59% specificity in patients who completed 3 visits. Receiver operating characteristic curve analysis revealed that the C-ACT was better than FeNO for identifying patients with not well-controlled asthma (area under the curve, 0.79; P < .001 [C-ACT] vs .58, P = .10 [FeNO]) Results of multivariate generalized estimating equation analysis revealed that a C-ACT score of 22 or less (odds ratio, 8.75; 95% confidence interval, 4.35-17.59; P < .001) and an FeNO of 19 ppb or greater (odds ratio, 2.60; 95% confidence interval, 1.07-6.29; P = .03) were significant indicators for the presence of not well-controlled asthma.
Conclusion:
The C-ACT is superior to FeNO in determining the control status of children with asthma and may be used as a complementary tool in clinical practice to detect children with not well-controlled asthma.
Related Concept Videos
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:30Asthma-IV: Nursing Management
First, in...
01:13Asthma III: Clinical Manifestations
01:26Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:23Assessment of Respiration
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like asthma or COPD,...